BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34645505)

  • 1. L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.
    Giordano M; Decio A; Battistini C; Baronio M; Bianchi F; Villa A; Bertalot G; Freddi S; Lupia M; Jodice MG; Ubezio P; Colombo N; Giavazzi R; Cavallaro U
    J Exp Clin Cancer Res; 2021 Oct; 40(1):319. PubMed ID: 34645505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
    Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-6 mediates platinum-induced enrichment of ovarian cancer stem cells.
    Wang Y; Zong X; Mitra S; Mitra AK; Matei D; Nephew KP
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Gla Protein drives stemness and tumor initiation in ovarian cancer.
    Nieddu V; Melocchi V; Battistini C; Franciosa G; Lupia M; Stellato C; Bertalot G; Olsen JV; Colombo N; Bianchi F; Cavallaro U
    Cell Death Dis; 2023 Mar; 14(3):220. PubMed ID: 36977707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.
    Lupia M; Angiolini F; Bertalot G; Freddi S; Sachsenmeier KF; Chisci E; Kutryb-Zajac B; Confalonieri S; Smolenski RT; Giovannoni R; Colombo N; Bianchi F; Cavallaro U
    Stem Cell Reports; 2018 Apr; 10(4):1412-1425. PubMed ID: 29551673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL20RA signaling enhances stemness and promotes the formation of an immunosuppressive microenvironment in breast cancer.
    Gao W; Wen H; Liang L; Dong X; Du R; Zhou W; Zhang X; Zhang C; Xiang R; Li N
    Theranostics; 2021; 11(6):2564-2580. PubMed ID: 33456560
    [No Abstract]   [Full Text] [Related]  

  • 7. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
    Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
    J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling.
    Ning Y; Cui Y; Li X; Cao X; Chen A; Xu C; Cao J; Luo X
    Biomed Pharmacother; 2018 Jul; 103():262-271. PubMed ID: 29656182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
    Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
    J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.
    Abubaker K; Luwor RB; Zhu H; McNally O; Quinn MA; Burns CJ; Thompson EW; Findlay JK; Ahmed N
    BMC Cancer; 2014 May; 14():317. PubMed ID: 24886434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of ovarian cancer by low-intensity ultrasound through depletion of IL-6/STAT3 inflammatory pathway-maintained cancer stemness.
    Gong T; Zhang P; Jia L; Pan Y
    Biochem Biophys Res Commun; 2020 Jun; 526(3):820-826. PubMed ID: 32273089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer stem cells: still an elusive entity?
    Lupia M; Cavallaro U
    Mol Cancer; 2017 Mar; 16(1):64. PubMed ID: 28320418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EZH2-Mediated Downregulation of the Tumor Suppressor DAB2IP Maintains Ovarian Cancer Stem Cells.
    Zong X; Wang W; Ozes A; Fang F; Sandusky GE; Nephew KP
    Cancer Res; 2020 Oct; 80(20):4371-4385. PubMed ID: 32816909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis.
    Ning Y; Feng W; Cao X; Ren K; Quan M; Chen A; Xu C; Qiu Y; Cao J; Li X; Luo X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):19. PubMed ID: 30646963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.
    Chen MW; Yang ST; Chien MH; Hua KT; Wu CJ; Hsiao SM; Lin H; Hsiao M; Su JL; Wei LH
    Cancer Res; 2017 Apr; 77(8):1955-1967. PubMed ID: 28209618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer stem cells through L1CAM suppresses glioma growth.
    Bao S; Wu Q; Li Z; Sathornsumetee S; Wang H; McLendon RE; Hjelmeland AB; Rich JN
    Cancer Res; 2008 Aug; 68(15):6043-8. PubMed ID: 18676824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
    Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
    Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation.
    Bondong S; Kiefel H; Hielscher T; Zeimet AG; Zeillinger R; Pils D; Schuster E; Castillo-Tong DC; Cadron I; Vergote I; Braicu I; Sehouli J; Mahner S; Fogel M; Altevogt P
    Ann Oncol; 2012 Jul; 23(7):1795-802. PubMed ID: 22228447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZnAs@SiO
    Huang Y; Zhou B; Luo H; Mao J; Huang Y; Zhang K; Mei C; Yan Y; Jin H; Gao J; Su Z; Pang P; Li D; Shan H
    Theranostics; 2019; 9(15):4391-4408. PubMed ID: 31285768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.